XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
DEBT (Tables)
6 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Schedule of Debt

Weighted-Average Effective

Interest Rate as of

Balance as of

 

June 30, 

 

December 31, 

 

 

June 30, 

 

December 31, 

($ in thousands)

2022

2021

Maturity Date

2022

2021

Line of credit (1)

 

3.08

1.40

%  

March 2025

$

670,000

$

Term loan (2)

 

2.87

 

2.23

 

March 2027

 

550,000

 

415,000

Term loan (3)

3.32

1.66

May 2026

600,000

600,000

Fixed-rate mortgage notes (4)

 

2.93

 

2.93

 

August 2024 -
January 2029

 

628,890

 

628,890

Floating-rate mortgage notes (5)

3.41

1.74

January 2025 -
July 2025

617,250

617,250

Total principal amount / weighted-average (6)

 

3.13

%  

2.14

%  

$

3,066,140

$

2,261,140

Less unamortized debt issuance costs

  

(23,332)

(16,106)

Add unamortized mark-to-market adjustment on assumed debt, net

  

 

533

 

639

Total debt, net

  

$

3,043,341

$

2,245,673

Gross book value of properties encumbered by debt

  

$

2,381,583

$

1,835,561

(1)The effective interest rate is calculated based on either (i) the Term Secured Overnight Financing Rate (“Term SOFR”) plus a 10 basis point adjustment (“Adjusted Term SOFR”) plus a margin ranging from 1.25% to 2.00%; or (ii) an alternative base rate plus a margin of 0.25% to 1.0%, depending on the Company’s consolidated leverage ratio. Customary fall-back provisions apply if Term SOFR is unavailable. The line of credit is available for general corporate purposes including, but not limited to, the acquisition and operation of permitted investments by the Company. As of June 30, 2022, total commitments for the line of credit were $1.0 billion and the unused and available portions under the line of credit were both $330.0 million.
(2)The effective interest rate is calculated based on either (i) Adjusted Term SOFR plus a margin ranging from 1.20% to 1.90%; or (ii) an alternative base rate plus a margin of 0.20% to 0.90%, depending on the Company’s consolidated leverage ratio. The weighted-average effective interest rate is the all-in interest rate, including the effects of interest rate swap agreements which fix Term SOFR for the term loan. As of June 30, 2022, total commitments for the term loan were $550.0 million. This term loan is available for general corporate purposes including, but not limited to, the acquisition and operation of permitted investments by the Company.
(3)The effective interest rate is calculated based on Term SOFR plus a 11.448 basis point adjustment (“Term Loan Adjusted Term SOFR”) plus a margin ranging from 1.35% to 2.20%; or (ii) an alternative base rate plus a margin ranging from 0.35% to 1.20%, depending on the Company’s consolidated leverage ratio. The weighted-average effective interest rate is the all-in interest rate, including the effects of interest rate swap agreements which fix Term SOFR for the term loan. As of June 30, 2022, total commitments for the term loan were $600.0 million. This term loan is available for general corporate purposes including, but not limited to, the acquisition and operation of permitted investments by the Company.
(4)Interest rates range from 2.85% to 3.75%. The assets and credit of each of the Company’s consolidated properties pledged as collateral for the Company’s mortgage notes are not available to satisfy the Company’s other debt and obligations, unless the Company first satisfies the mortgage notes payable on the respective underlying properties.
(5)The effective interest rate of the $209.3 million mortgage note is calculated based on LIBOR plus a margin of 1.50%. The effective interest rate of the $408.0 million mortgage note is calculated based on Adjusted Term SOFR plus a margin of 1.65%.
(6)The weighted-average remaining term of the Company’s consolidated debt was approximately 4.0 years as of June 30, 2022, excluding any extension options on the line of credit and the floating-rate mortgage notes.
Schedule of Maturities of Long-term Debt

As of June 30, 2022, the principal payments due on the Company’s consolidated debt during each of the next five years and thereafter were as follows:

(in thousands)

 

Line of Credit (1)

 

Term Loans

 

Mortgage Notes (2)

 

Total

Remainder of 2022

 

$

$

$

$

2023

 

 

 

 

2024

 

 

 

38,000

 

38,000

2025

 

670,000

 

 

617,250

 

1,287,250

2026

 

 

600,000

 

600,000

Thereafter

 

 

550,000

 

590,890

 

1,140,890

Total principal payments

$

670,000

$

1,150,000

$

1,246,140

$

3,066,140

(1)The line of credit term may be extended pursuant to two one-year extension options, subject to certain conditions.
(2)The $209.3 million mortgage note term may be extended pursuant to a one-year extension option, subject to certain conditions. The $408.0 million mortgage note term may be extended pursuant to two one-year extension options, subject to certain conditions.
Schedule of Derivative Instruments

The following table summarizes the location and fair value of the derivative instruments on the Company’s condensed consolidated balance sheets as of June 30, 2022 and December 31, 2021.

 

Number of

 

Notional

 

Balance Sheet

 

Fair

($ in thousands)

Contracts

Amount

Location

Value

As of June 30, 2022

 

  

 

 

  

  

 

  

Interest rate swaps

 

16

$

1,075,000

 

Other assets

$

28,280

Interest rate caps

2

578,000

Other assets

18,002

Total derivative instruments

18

$

1,653,000

$

46,282

As of December 31, 2021

 

  

 

 

  

  

 

  

Interest rate swaps

 

10

$

575,000

 

Other assets

$

2,653

Interest rate caps

2

578,000

Other assets

3,164

Total derivative instruments

12

$

1,153,000

$

5,817

Derivative Instruments, Gain (Loss)

The following table presents the effect of the Company’s derivative instruments on the Company’s condensed consolidated financial statements.

For the Three Months Ended June 30, 

For the Six Months Ended June 30, 

(in thousands)

 

2022

 

2021

 

2022

 

2021

Derivative Instruments Designated as Cash Flow Hedges

 

  

 

  

 

  

 

  

Gain (loss) recognized in AOCI

$

5,902

$

(81)

$

23,940

$

1,394

Amount reclassified from AOCI into interest expense

 

546

 

917

 

1,692

 

1,804

Total interest expense presented in the condensed consolidated statements of operations in which the effects of the cash flow hedges are recorded

 

33,078

 

4,571

 

55,545

 

8,295

Derivative Instruments Not Designated as Cash Flow Hedges

Gain recognized in income

$

3,937

$

$

14,839

$